Dentist, General Practice · Flushing, NY
NPI
1932127586
Since 2006
Specialty
Dentist, General Practice
Code 1223G0001X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
4211 Kissena Blvd Apt 1d
Flushing, NY, 11355
Phone (718) 353-5504
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$6,545
1,250 prescriptions
Company payments, 2025
$1,832
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Richard L Yang prescribed most often to Medicare patients was Amoxicillin, with 512 prescriptions and refills. In total Richard L Yang wrote 1,250 Medicare prescriptions that cost $6,545.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-12-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Amoxicillin Generic | 512 | 512 | 369 | $1,362 |
| Ibuprofen Generic | 347 | 347 | 277 | $998 |
| Chlorhexidine Gluconate Generic | 196 | 199 | 131 | $791 |
| Sodium Fluoride 5000 Plus Fluoride (Sodium) | 42 | 42 | 14 | $181 |
| Clindamycin Hcl Generic | 30 | 30 | 24 | $248 |
| Sf 5000 Plus Fluoride (Sodium) | 28 | 28 | 13 | $101 |
| Prevident 5000 Sensitive Sodium Fluoride/Potassium Nit | 17 | 19 | Under 11 | $368 |
| Denta 5000 Plus Fluoride (Sodium) | 14 | 14 | Under 11 | $95.53 |
| Ibu Ibuprofen | 13 | 13 | 11 | $32.01 |
| Sodium Fluoride Enamel Protect Sodium Fluoride/Potassium Nit | 12 | 12 | Under 11 | $139 |
Brand drugs: - claims; generic drugs: 1,114 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard L Yang $1,832 ($1,832 in general payments such as food, travel and fees) from 2 companies. The largest payer was A-dec, Inc. with $1,610.
| Company | Payments | Amount |
|---|---|---|
| A-dec, Inc. | 1 | $1,610 |
| Essential Dental Systems Incorporated | 2 | $222 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.